Theflash88
Posted - 21 hours ago
$LEGN High volume !
SamsonGray
Posted - 1 day ago
$LEGN $RGEN LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?
YesOneHundredPercent
Posted - 1 day ago
$LEGN where the 10Q for this bad boy....I looked on their site, nothing was filed.anybody has a thought on that?
stevenlzeng
Posted - 2 days ago
$LEGN Buy Buy Buy🚀🚀🚀
Rozer900
Posted - 4 days ago
$LEGN Legend Biotech’s breakthroughs in cell therapies keep it at the forefront of innovative cancer treatments!
smartkarma
Posted - 1 week ago
$LEGN | Legend Biotech (LEGN.US) Offer Update - Will Deconsolidation Increase the Chances of a Merger ?
"The deconsolidation of Legend Bio may not necessarily be directly related to a potential merger, but divisions among major shareholders/co-founders increases the probability of Legend Bio being sold." - Xinyao (Criss) Wang
Read more: https://www.smartkarma.com/insights/legend-biotech-legn-us-offer-update-will-deconsolidation-increase-the-chances-of-a-merger
MBSB
Posted - 1 week ago
$LEGN Legend Biotech Beat Consensus Estimates Tuesday, November 12, 2024 at 7:00 AM ET Legend Biotech (LEGN) reported a loss of $0.34 per share on revenue of $160.21 million for the third quarter ended September 2024. The consensus estimate was a loss of $0.56 per share on revenue of $144.70 million. The company beat consensus estimates by 39.29% while revenue grew 66.86% on a year-over-year basis
MoniBarnett
Posted - 1 week ago
💥 Boom 🚨 Big news! LFGOOOOOO! Mainz Biomed MYNZ has teamed up with Thermo Fisher TMO (mkt cap $209.2B, trading at ~$546.92) to develop a next-gen colorectal cancer screening tool for global markets. Thermo Fisher’s $42.4B annual revenue and advanced tech will boost MYNZ’s mRNA-based assays, hitting 85% detection for advanced adenomas vs. competitors’ 43% and 20%. With CRC cases up 500% in young people, MYNZ is leading early detection. Win-win for both sides — TMO stepping into the CRC market too. Big developments ahead! Calling all apes, let's crush these shorties—this time is bull time. Insane news, we've been waiting for!!! $LEGN $RGEN
jewell69
Posted - 1 week ago
$LEGN sold another piece. 50 at 40.66
Still own 200 with a cost of about 45
Definitely made money on the 90
and lost some on the 40.66 50 share order
jewell69
Posted - 1 week ago
$LEGN s 9:34 am est just 90
40.60. Earns out; loss less than expected Also less than same q 1 year ago
Revs up
Still a loss
$1.2$$BN of runway cash
monterocky848
Posted - 1 week ago
$LEGN sadly shareholders we are here to inform you we are going to have to accept a buyout at $125/share; shareholders enjoy your 💵💵💵we just don’t care anymore
jewell69
Posted - 1 week ago
@monterocky848 1 more tidbit $LEGN Legend Biotech has an analyst consensus of Strong Buy, with a price target consensus of $84.27, representing a 91.6% upside. In a report issued on October 15, BMO Capital also maintained a Buy rating on the stock with a $90.00 price target. BMO, Bank of Montreal for all you _ome Gamers
jewell69
Posted - 1 week ago
@monterocky848 $LEGN let me check TipRanks about 11/12 earnings
jewell69
Posted - 1 week ago
earns will be out 11/12 LEGEND BIOTECH CORP ADR $LEGN
Biotech2424
Posted - 1 week ago
7 approved indication for the Coherus pd-1 in China. If we can get half these it’s a billion dollar drug. Vanda has been getting non-stop takeover requests. Might start seeing that here too in Coherus. They could generate $375 million in revenues in 2025. Seems like bottom is in- and there’s 30 million shares of buying powder on the sidelines. Already approved in small $200 million dollar metastatic indication- but this can balloon up with 83 cent stock price to $3-5…
$CHRS $VNDA $SMMT $LEGN
stevenlzeng
Posted - 1 week ago
$LEGN Why is this dropping so much？
NoRisksNoFun
Posted - 1 week ago
$LEGN $BPMC $TGTX $AXSM l Gens bulls are in despair! Rollercoaster!
GemsOversold
Posted - 2 weeks ago
$LEGN
buddyopalosam
Posted - 1 month ago
$LEGN come on 39. Buyer there.
Thestocktraderhubzee
Posted - 1 month ago
$LEGN HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $73 Price Target
jewell69
Posted - 1 month ago
$LEGN bot today 10/15/24 47.35 and $AMD 156.874 bot some yesterday 10/14, and more today 10/15 of: $JIJAX $fiGrx DAY TRADED FOR +2.2% IN/ OUT $VIR
flytrader1
Posted - 1 month ago
$LEGN any reason for the selling pressure? Barclay's says it's a buying opp. But it seems like the brokers always get in wrong with their "buying opportunty" calls
jewell69
Posted - 1 month ago
$LEGN re-entry 10/15/24 9:45 am EDT Action Buy Quantity 250 Price $47.35 Principal -$11,837.50 SOLD 7/30 Date Jul-30-2024 Symbol LEGN Symbol description LEGEND BIOTECH CORP SPONSORED ADS Type Margin Shares -60.000 Price $56.65 Amount $3,398.90
jewell69
Posted - 1 month ago
Patients with advanced multiple myeloma now have a second option for CAR T-cell therapy, a type of personalized immunotherapy. On February 28, 2022 the Food and Drug Administration (FDA) approved ciltacabtagene autoleucel (Carvykti) for adults with multiple myeloma that is not responding to treatment (refractory) or has returned after treatment (relapsed). Under the approval, ciltacabtagene autoleucel, also called cilta-cel, can be taken by people who have already received four or more lines of therapy, including treatment with three major classes of multiple myeloma drugs (an immunomodulating agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody). CARVKTI is its name $LEGN
jewell69
Posted - 1 month ago
Legend Biotech $LEGN 7/30 Date SOLD Jul-30-2024 Symbol LEGN Symbol description LEGEND BIOTECH CORP SPONSORED ADS Type Margin Shares -60.000 Price $56.65 In a report released today, Gena Wang from Barclays maintained a Buy rating on Legend Biotech, with a price target of $94.00. The company’s shares closed last Friday 8/9/24 at $55.90. MITE BUY TODAY 10/15
smartkarma
Posted - 1 month ago
$LEGN | Legend Biotech (LEGN.US) Offer Update - Is the Deal Really Dead?
"Given the geopolitical risks, this acquisition is worth considering for both Legend Bio and Genscript. However, the main obstacles are disagreement over price and personnel arrangement for Legend Bio." - Xinyao (Criss) Wang
Read more: https://www.smartkarma.com/insights/legend-biotech-legn-us-offer-update-is-the-deal-really-dead
Zit1343
Posted - 1 month ago
$LEGN
OpenOutcrier
Posted - 09/30/24
$LEGN (+2.4% pre) CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line - SI https://ooc.bz/l/43577
themacromindset
Posted - 09/30/24
$LEGN $LEGN CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
